Highlights the critical need to recognize and apply gender-specific symptomatology and risk factors to improve cardiovascular disease management and outcomes in women.
Cardiovascular disease (CVD) in women remains under-diagnosed and undertreated due to the diagnostic challenge it presents, as well as the persisting attitude that CVD predominantly affects men. Gender-related risk factors have now been identified but there is a lack of clinical application, leading to the misdiagnosis and poor management of women with CVD. It is necessary to address gender-specific symptomatology and risk factors in order to optimise management and positively influence morbidity and mortality in this cohort of patients.
Keteepe‐Arachi et al. (Sun,) studied this question.